JAGX Overview
Upcoming Projects (JAGX)
-
Don’t see a project related to the company you care about? Create your own!
Expired Projects (JAGX)
-
What's the potential of Neonorm in farm animals? An interview with a farm Veterinarian about the market and alternative treatment options.
Tickers: JAGX, ZTS
Execute By: Jan 31, 2016
Upcoming & Overdue Catalysts (JAGX)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (JAGX)
-
Jaguar Animal Health (JAGX) Announces $1MM Private Placement of Common Stock and Warrants
Ticker: JAGX
Occurred on: Nov 23, 2016 -
Jaguar Animal Health Announces $15 Million Common Stock Purchase Agreement with Aspire Capital Fund, LLC
Ticker: JAGX
Occurred on: Jun 09, 2016 -
Data from SB-300's Proof of Concept Trial for Treatment of Gastrointestinal Ulcers in Horses
Ticker: JAGX
Occurred on: Feb 16, 2016 -
Jaguar Animal Health Prices 2,000,000 Common Share Offering at $2.50 per share
Ticker: JAGX
Occurred on: Feb 03, 2016
Strategic Initiatives (JAGX)
-
Jaguar Animal Health (JAGX) to Launch National TV and Radio Ad Campaign for Neonorm Product Line for Severe Diarrhea in Calves and Horses
Ticker: JAGX
Announcement Date: Apr 06, 2017 -
Jaguar (JAGX) Promotes Dehydration Treatment Neonorm at American Association of Equine Practitioners Annual Meeting
Ticker: JAGX
Announcement Date: Dec 09, 2016 -
Jaguar (JAGX) and Napo Pharmaceuticals Sign Non-Binding Letter of Intent (LOI) Preparing to Merge
Tickers: JAGX, Napo Pharmaceuticals
Announcement Date: Oct 06, 2016
